Studies of longitudinally sampled sera from 16 SLE patients revealed that the presence and levels of anti-KIR autoantibodies were relatively stable over time (Supplementary Figure S2), but some patients acquired new anti-KIR-specificities and some patients lost KIR-reactivity over time. This evidence concerns the gene KIR3DL1 and systemic lupus erythematosus.